Similar articles

• Suppression of experimental allergic encephalomyelitis by tilorone: cell transfer and interferon studies.

  Levine S, Sowinski R, Abreu SL. Levine S, et al. Immunopharmacology. 1983 Jun;6(1):23-30. doi: 10.1016/0162-3109(83)90013-9. Immunopharmacology. 1983. PMID: 6223898
• Necrotic myelopathy (myelomalacia) in rats with allergic encephalomyelitis treated with tilorone.

  Levine S, Sowinski R. Levine S, et al. Am J Pathol. 1976 Feb;82(2):381-92. Am J Pathol. 1976. PMID: 1082719 Free PMC article.
• Suppression of the hyperacute form of experimental allergic encephalomyelitis by drugs.

  Levine S, Sowinski R. Levine S, et al. Arch Int Pharmacodyn Ther. 1977 Dec;230(2):309-18. Arch Int Pharmacodyn Ther. 1977. PMID: 603323
• [Experimental allergic encephalomyelitis--clinical aspects and treatment].

  Błaszczyk B. Błaszczyk B. Postepy Hig Med Dosw. 1979 Jan-Feb;33(1):77-88. Postepy Hig Med Dosw. 1979. PMID: 86987 Review. Polish. No abstract available.
• Immunotherapy of autoimmune disease with T cell subset specific antibodies.

  Sriram S, Ranges GE. Sriram S, et al. Concepts Immunopathol. 1987;4:275-86. Concepts Immunopathol. 1987. PMID: 3297338 Review. No abstract available.